Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use

Claim 2

A process for the preparation of an active agent containing controlled release diffusion device comprising a swellable hydrogel matrix in the non-swollen state, interpenetrated with an active agent solute having a stable concentration distribution increasing in a gradient normal to the surface of the device and between the surface and the core thereof, said gradient being in the form of a substantially continuous inflection point containing, sigmoidal curve such that the device, when placed in an aqueous hydrogel swelling environment, releases said active agent in a controlled continous manner by diffusion for a predetermined period of time into said aqueous environment comprising (a) washing the surface of an active agent uniformly loaded hydrogel device which is in the non-swollen or glassy, state, with a volatile swelling solvent for a time sufficient for the solvent to penetrate the outer surface thereof such that the hydrogel device has an outer swollen, or rubbery phase and an inner non-swollen, or glassy, core to thereby extract a portion of the active active agent from the rubbery phase and generate an active agent concentration gradient in the form of a substantially continuous, inflection point containing, sigmoidal curve; (b) removing the volatile swelling solvent from the swollen portion of the device at a rate sufficient to immobilize the active agent profile in the form of said continous, inflection point containing, sigmoidal curve; and (c) recovering the resultant non-swollen controlled release diffusion device.

Claim 3

A process for the preoparation of an active agent containing controlled release diffusion device comprising a swellable hydrogel matrix in the non-swollen state, interpenetrated with an active agent solute having a stable concentration distirbution increasing in a gradient normal to the surface of the device and between the surface and the core thereof, said gradient being in the form of a substantially continuous, inflection point containing, sigmoidal curve, wherein the core is substantially uniformly loaded with active agent and extends outwardly from the center of the device to about 1 to about 60 percent of the radius of the device; the sigmoidal concentration gradient of the active agent extending outwardly from said core to cover about 99 to about 30 percent of the radus of the device, the remainder, up to about 10 percent of the outermost portion of the radius to the surface of the device, contains a conentration of active agent of no more than 10 weight percent per unit volume as compared to the core concentration of active agent, such that the device, when placed in an aqueous hydrogel swelling environment, releases said active agent in a controlled continuous manner by diffusion for a predetermined period of time into said aqueous environment comprising (a) washing the surface of an active agent uniformly loaded hydrogel device which is in the non-swollen or glassy, state, with a volatile swelling solvent for a time sufficient for the solvent to penetrate the outer surface thereof such that the device has an outer swollen, or rubbery phase and an inner non-swollen, or glassy, core to thereby extract a portion of the active agent from the rubbery phase and generate an active agent concentration gradient in the form of a substantially continuous, inflection point containing, sigmoidal curve; (b) removing the volatile swelling solvent from the swollen portion of the device at a rate sufficient to immobilize the active agent profile in the form of said continuous, inflection point containing, sigmoidal curve; and (c) recovering the resultant non-swollen controlled release diffusion device.

Claim 4

A process for the preoparation of an active agent containing controlled release diffusion device comprising a swellable hydrogel matrix in the non-swollen state, interpenetrated with an active agent solute having a stable concentration distirbution increasing in a gradient normal to the surface of the device and between the surface and the core thereof, said gradient being in the form of a substantially continuous, inflection point containing, sigmoidal curve, wherein the core is substantially uniformly loaded with active agent and extends outwardly from the center of the device to about 1 to about 60 percent of the radius of the device; the sigmoidal concentration gradient of the active agent extending outwardly from said core to cover about 99 to about 30 percent of the radus of the device, the remainder, up to about 10 percent of the outermost portion of the radius to the surface of the device, contains a conentration of active agent of no more than 10 weight percent per unit volume as compared to the core concentration of active agent, such that the device, when placed in an aqueous hydrogel swelling environment, releases said active agent in a controlled continuous manner by diffusion for a predetermined period of time into said aqueous environment comprising (a) washing the surface of an active agent uniformly loaded hydrogel device which is in the non-swollen or glassy, state, with a volatile swelling solvent for a time sufficient for the solvent to penetrate the outer surface thereof such that the device has an outer swollen, or rubbery phase and an inner non-swollen, or glassy, core to thereby extract a portion of the active agent from the rubbery phase and generate an active agent concentration gradient in the form of a substantially continuous, inflection point containing, sigmoidal curve; (b) removing the volatile swelling solvent from the swollen portion of the device at a rate sufficient to immobilize the active agent profile in the form of said continuous, inflection point containing, sigmoidal curve; and (c) recovering the resultant non-swollen controlled release diffusion device.

Claim 5

A process for the preparation of a controlled release diffusion device by the process comprising (a) washing the surface of an active agent uniformly loaded hydrogel device which is in the non-swollen or glassy, state, with a volatile swelling solvent for a time sufficient for the solvent to penetrate the outer surface thereof such that the device has an outer swollen, or rubbery phase and an inner non-swollen, or glassy, core to thereby extact a portion of a active agent from the rubbery phase and generate an active agent concentration gradient in the form of a substantially continuous, inflection point containing, sigmoidal curve; (b) removing the volatile swelling solvent from the swollen portion of the device at a rate sufficient to immobilize the active agent profile in the form of said continuous, inflection point containing, sigmoidal curve; and (c) recovering the resultant non-swollen device.

Claim 6

A process for the preparation of a controlled release diffusion device by the process comprising (a) washing the surface of an active agent uniformly loaded hydrogel device which is in the non-swollen or glassy, state, with a volatile swelling solvent for a time sufficient for the solvent to penetrate the outer surface thereof such that the device has an outer swollen, or rubbery phase and an inner non-swollen, or glassy, core to thereby extact a portion of a active agent from the rubbery phase and generate an active agent concentration gradient in the form of a substantially continuous, inflection point containing, sigmoidal curve; (b) removing the volatile swelling solvent from the swollen portion of the device at a rate sufficient to immobilize the active agent profile in the form of said continuous, inflection point containing, sigmoidal curve; and (c) recovering the resultant non-swollen device.

Claim 7

The process according to claim 3, wherein the device is in the form of a bead.

Claim 8

The process according to claim 4, wherein the bead has a diameter between about 0.01mm to about 20mm.

Claim 9

The process according to claim 3, wherein the active agent is a drug.

Claim 10

A device according to claim 5, wherein the active agent is a drug.

Claim 11

A device according to claim 3, wherein at least 40 weight percent of the active agent is released at a substantially zero-order rate.

Claim 12

The process according to claim 3, wherein at least 50 weight percent of the active agent is released at a substantially zero-order rate.

Claim 13

The process in the form of a bead according to claim 2, wherein the core is substantially uniformly loaded with active agent and extends outwardly from the center of the bead to about 1 to about 60 percent of the radius of said bead; the sigmoidal concentration gradient of the active agent extends outwardly from said core to cover about 99 to about 30 percent of the radius of said bead, and the remainder, up to about 10 percent of the outermost portion of the radius to the surface of the bead, is at least partially depleted of active agent.

Claim 14

The process according to claim 7, where said outermost portion of the radius of the bead contains not more than 10% per unit volume of active agent as compared to the core concentration of active agent.

Claim 15

The process according to claim 3 wherein the hydrogel is substantially insoluble in the aqueous swelling environment of use.

Claim 16

The process according to claim 12, where the hydrogel is a crosslinked water-swellable polymer.

Claim 17

A process according to claim 3, wherein extraction step (a) is conducted between -20° C. up to about 120° C. but not exceeding the gloss transition temperature of the active agent loaded hydrogel.

Claim 18

A process according to claim 3 where the volatile solvent removal step (b) is conducted at a pressure below 70mm Hg.

Claim 19

A process according to claim 15, where the volatile solvent removal step (b) is conducted under substantially adiabatic conditions.

Claim 20

A process according to claim 3, where between about 15 to 98 volume percent of the device is at least partially swollen by the volatile swelling solvent.

Claim 21

A process according to claim 3, wherein between about 7 to 80 weight percent of active agent relative to the amount of active agent in said loaded device is removed from the device during the extraction step (a).